Ying Pai Pharmaceutical seeks to raise up to HK$913 million through a Hong Kong IPO.

According to the documents submitted to the Hong Kong Stock Exchange, Nanjing Yingpai Pharmaceutical Co., Ltd. is planning to issue approximately 42 million shares at a price range of HK$19.75 to HK$21.75 per share. It is estimated that the company will raise a maximum of HK$913 million. The company will be listed for trading on May 13th, with Goldman Sachs and CICC as joint sponsors.